Preventing newborn breathing problems with steroids
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests a plan to prevent a severe newborn breathing problem called NARDS. If your baby's risk is very high, you may be offered a steroid treatment that could help their lungs work better at birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and your baby has a high risk (over 80% chance) of a serious breathing problem called neonatal acute respiratory distress syndrome (NARDS).
- You agree to receive a steroid medicine (called antenatal corticosteroids or ACS) to lower this risk.
- You have signed a consent form agreeing to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at giving a “surfactant” medicine (a substance that helps keep baby lungs open) to newborns who have serious breathing problems soon after birth. It may help babies with neonatal respiratory distress or acute breathing distress, especially if they’re treated in the early time window.
This study tests if adding a type of steroid (glucocorticoid) to standard treatment helps people on a breathing machine recover from severe lung failure (ARDS). It compares different doses to see which works best.
This study tests whether a steroid medicine called dexamethasone can help prevent a serious lung problem in very premature babies who need a breathing machine for a long time. It may help babies who are still on the machine after two weeks and need high levels of oxygen.
This study looks at whether giving steroids before a planned C-section at full term can help babies breathe better after birth. It may be an option for pregnant women who are scheduled for a C-section and meet certain health criteria.
This trial tests whether a steroid called betamethasone, given after birth, helps extremely premature babies (born before 28 weeks) come off breathing support safely. It aims to make weaning from a ventilator quicker and safer.
This trial studies whether dexamethasone (a steroid medicine) improves outcomes in adults who have sudden, severe breathing failure caused by an infection while they are on a breathing machine. It may help reduce inflammation in the lungs during critical illness.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.